ACP Letter regarding H.R. 4895, the Lowering Drug Costs for American Families Act

ACP expresses support for H.R. 4895, the Lowering Drug Costs for American Families Act, which would build upon the historic drug pricing provisions in the Inflation Reduction Act of 2022, further strengthening Medicare's Drug Pricing Program.

Vy Oxman

H.R. 4895, cost of prescription drugs, prescription drugs, Medicare drug pricing program, drug negotiation, S. 652; H.R.2630; The Safe Step Act; step therapy; nonmedical drug switching; patient access; pharmaceuticals; rising healthcare costs; patient care; medication non-adherence; Lowering Drug Costs for American Families Act; Pallone; Neal; Scott; Elijah E. Cummings Lower Drug Costs Now Act; Drug Negotiation Program; negotiating authority

Thu, 09/14/2023 - 3:19 PM EDT

Thu, 09/14/2023 - 3:50 PM EDT

3

acp_letter_regarding_lowering_drug_costs_for_american_families_act_2023.pdf

{"Author":"Vy Oxman","CreationDate":"2023-09-14T15:19:51-04:00","Creator":"Microsoft\u00ae Word for Microsoft 365","Keywords":"H.R. 4895, cost of prescription drugs, prescription drugs, Medicare drug pricing program, drug negotiation, S. 652; H.R.2630; The Safe Step Act; step therapy; nonmedical drug switching; patient access; pharmaceuticals; rising healthcare costs; patient care; medication non-adherence; Lowering Drug Costs for American Families Act; Pallone; Neal; Scott; Elijah E. Cummings Lower Drug Costs Now Act; Drug Negotiation Program; negotiating authority","ModDate":"2023-09-14T15:50:37-04:00","Producer":"Microsoft\u00ae Word for Microsoft 365","Title":"ACP Letter regarding H.R. 4895, the Lowering Drug Costs for American Families Act","Subject":"","Pages":3}

2023